GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sarepta Therapeutics Inc (SRPT) [hlAlert]

Rating:
Outperform
SRPT
up 64.90 %

Sarepta Therapeutics Inc (SRPT) rated Outperform with price target $45 by Oppenheimer

Posted on: Friday,  Aug 1, 2014  12:00 AM ET by Oppenheimer

Oppenheimer rated Outperform Sarepta Therapeutics Inc (NASDAQ: SRPT) on 08/01/2014, when the stock price was $21.97. Since
then, Sarepta Therapeutics Inc has gained 64.91% as of 01/19/2016's recent price of $36.23.
If you would have followed this Oppenheimer's recommendation on SRPT, you would have gained 64.9% of your investment in 536 days.

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/1/2014 12:00 AM Buy
None
21.97 45.00
as of 10/17/2014
1 Week up  18.80 %
1 Month down  -2.78 %
3 Months up  1.50 %
1 YTD up  1.50 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy